Sionna Therapeutics (NASDAQ:SION) Earns Buy Rating from Analysts at TD Cowen
Research analysts at TD Cowen started coverage on shares of Sionna Therapeutics (NASDAQ:SION – Get Free Report) in a research report issued to clients and investors on Tuesday, Marketbeat.com reports. The brokerage set a “buy” rating on the stock. A number of other brokerages have also weighed in on SION. Guggenheim began coverage on shares […]
Research analysts at TD Cowen started coverage on shares of Sionna Therapeutics (NASDAQ:SION – Get Free Report) in a research report issued to clients and investors on Tuesday, Marketbeat.com reports. The brokerage set a “buy” rating on the stock. A number of other brokerages have also weighed in on SION. Guggenheim began coverage on shares […]
